Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity
Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brai...
Saved in:
Published in | Neuropsychopharmacology (New York, N.Y.) Vol. 49; no. 9; pp. 1481 - 1490 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Nature Publishing Group
01.08.2024
Springer International Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18–55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10–80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings (
ES
= 35.30,
p
< 0.001) and heart rate (
ES
= 11.15,
p
= 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores,
r
= 0.32,
p
< 0.001; RSFC between bilateral mPFC and DEQ scores, r = –0.28,
p
= 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at
p
= 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073–0.1 Hz frequency range at
p
< 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717). |
---|---|
AbstractList | Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18-55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10-80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings (ES = 35.30, p < 0.001) and heart rate (ES = 11.15, p = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r = 0.32, p < 0.001; RSFC between bilateral mPFC and DEQ scores, r = -0.28, p = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073-0.1 Hz frequency range at p < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717). Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18-55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10-80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings (ES = 35.30, p < 0.001) and heart rate (ES = 11.15, p = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r = 0.32, p < 0.001; RSFC between bilateral mPFC and DEQ scores, r = -0.28, p = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073-0.1 Hz frequency range at p < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717).Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18-55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10-80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings (ES = 35.30, p < 0.001) and heart rate (ES = 11.15, p = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r = 0.32, p < 0.001; RSFC between bilateral mPFC and DEQ scores, r = -0.28, p = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073-0.1 Hz frequency range at p < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717). Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18–55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10–80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings ( ES = 35.30, p < 0.001) and heart rate ( ES = 11.15, p = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r = 0.32, p < 0.001; RSFC between bilateral mPFC and DEQ scores, r = –0.28, p = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073–0.1 Hz frequency range at p < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717). Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18–55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10–80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings (ES = 35.30, p < 0.001) and heart rate (ES = 11.15, p = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r = 0.32, p < 0.001; RSFC between bilateral mPFC and DEQ scores, r = –0.28, p = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073–0.1 Hz frequency range at p < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717). |
Author | Gilman, Jodi M. Pachas, Gladys N. Potter, Kevin Evins, A. Eden Pascale, Michael Ozana, Nisan Karunakaran, Keerthana Deepti |
Author_xml | – sequence: 1 givenname: Keerthana Deepti surname: Karunakaran fullname: Karunakaran, Keerthana Deepti – sequence: 2 givenname: Michael orcidid: 0000-0002-4381-224X surname: Pascale fullname: Pascale, Michael – sequence: 3 givenname: Nisan surname: Ozana fullname: Ozana, Nisan – sequence: 4 givenname: Kevin surname: Potter fullname: Potter, Kevin – sequence: 5 givenname: Gladys N. surname: Pachas fullname: Pachas, Gladys N. – sequence: 6 givenname: A. Eden surname: Evins fullname: Evins, A. Eden – sequence: 7 givenname: Jodi M. orcidid: 0000-0001-5180-6694 surname: Gilman fullname: Gilman, Jodi M. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38714786$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc9OXCEYxUljU0ftC3RhSLpxg_If7soY01YTEzc1cUe4XKaDuQMjcI3T5_C5-kxFR0110RUhnHM43_fbAVsxRQ_AF4IPCWb6qHDCtESYcoSJVhKJD2BGFMdIMn69BWZYdwwRxq63wU4pNxgToaT-BLaZVoQrLWfAn8ea7oOzNaQIh8nDmuCfhw5VX7NdrIecnI3R9iGmEYYC3cJm66rP4bcfYL-GQyh5WtV2WWU_zylWO0KXcvX3sAnDXajrPfBxbsfiPz-fu-Dq-7efp2fo4vLH-enJBXKckYoGTWjHyKAcx6pzTNJOUSFpL-hczZ2j1g6US9JhJTClPXUMa2kZ9710WnZsFxxvcldTv_SD87ENMZpVDkub1ybZYN6-xLAwv9KdIYQKQpRuCQfPCTndTr5UswzF-XG00aepGIYFFZ2Q-vGzr--kN2nKsc3XVBo3IEriptr_t9JrlxcETaA3ApdTKW2FxoX6hKM1DKMh2DzSNhvaptE2T7SNaFb6zvqS_h_TXwAPrpo |
CitedBy_id | crossref_primary_10_1124_jpet_123_001987 |
Cites_doi | 10.1016/j.neuroimage.2009.09.037 10.1016/0013-4694(87)90206-9 10.1038/nature20153 10.21037/tp-21-412 10.1016/j.neubiorev.2009.07.008 10.1093/brain/awad389 10.1111/nyas.13948 10.3389/fnhum.2016.00216 10.1111/adb.12870 10.31707/VDR2019.5.1.p31 10.1017/S1461145711000526 10.1364/AO.48.00D280 10.1001/archgenpsychiatry.2011.161 10.1016/S1566-0702(01)00289-2 10.1007/BF02447083 10.1371/journal.pone.0053127 10.3389/fnhum.2017.00258 10.1088/0967-3334/31/5/004 10.2174/138161210791293097 10.1371/journal.pone.0070074 10.1038/s41386-021-01259-0 10.1177/0269881119841568 10.1007/978-3-030-32254-0_17 10.1111/j.2517-6161.1995.tb02031.x 10.1016/j.neuroimage.2019.05.012 10.1038/s41386-024-01809-2 10.1002/j.1552-4604.2002.tb06005.x 10.1097/00007691-199810000-00021 10.3390/a11050067 10.1007/s00213-012-2954-z 10.1007/s12021-020-09500-9 10.1038/s41598-022-06509-9 10.3791/53336 10.1093/jat/bkx012 10.1007/s00213-006-0508-y 10.1038/srep17471 10.1016/j.neubiorev.2021.11.004 10.1038/npp.2014.258 10.1002/hbm.22140 10.1016/j.euroneuro.2018.12.003 10.1001/jamapsychiatry.2023.2309 10.1016/j.neubiorev.2021.01.003 10.3389/fnhum.2017.00488 10.1111/psyp.13955 10.1080/15389588.2020.1851685 10.1016/j.nicl.2016.05.011 10.1007/s11682-015-9488-z 10.1371/journal.pone.0052545 10.1016/j.euroneuro.2014.11.018 10.1007/s00213-007-0940-7 10.1016/j.neuroimage.2007.02.041 10.1038/s41583-021-00466-4 10.3389/fpsyt.2021.689444 10.1016/j.euroneuro.2020.01.006 10.1093/schbul/sbv064 10.1093/cercor/bhj136 10.1016/j.neuroscience.2016.09.034 10.1016/j.neuroimage.2012.03.070 10.1016/j.neuroimage.2012.01.044 10.3389/fnins.2019.01430 10.1016/j.neuroimage.2012.11.038 10.1073/pnas.1422487112 |
ContentType | Journal Article |
Copyright | 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
Copyright_xml | – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1038/s41386-024-01876-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef ProQuest One Psychology |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1740-634X |
EndPage | 1490 |
ExternalDocumentID | PMC11251178 38714786 10_1038_s41386_024_01876_5 |
Genre | Randomized Controlled Trial Journal Article |
GrantInformation_xml | – fundername: NIDA NIH HHS grantid: R42 DA043977 – fundername: NIDA NIH HHS grantid: K02 DA052684 – fundername: NIDA NIH HHS grantid: K24 DA030443 – fundername: NIDA NIH HHS grantid: R01 DA042043 |
GroupedDBID | --- -DZ 0R~ 29N 2WC 36B 39C 4.4 406 5RE 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAYXX AAYZH ABAKF ABBRH ABDBE ABFSG ABIVO ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMFV ACMJI ACPRK ACSTC ACZOJ ADBBV ADFRT AEFQL AEJRE AEMSY AENEX AESKC AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ASPBG ATHPR AVWKF AYFIA AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION CS3 DIK DNIVK DPUIP DWQXO E3Z EBLON EBS EE. F5P FDB FDQFY FIGPU FYUFA GNUQQ GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JZLTJ KQ8 LGEZI LOTEE M1P M2M M7P NADUK NQJWS NXXTH O9- OK1 P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO PSYQQ Q2X RNT RNTTT ROL RPM SNX SNYQT SOJ SRMVM SWTZT TAOOD TR2 UKHRP W2D ZGI --K -Q- 1B1 53G 5VS AAEDT AALRI AAQFI AAQXK AAXUO ABMAC ABWVN ACIUM ACRPL ACRQY ADMUD ADNMO CAG CGR COF CUY CVF ECM EIF EIOEI EJD EMB EMOBN FEDTE FERAY FGOYB FIZPM FSGXE HVGLF IHE M41 MK0 NPM NQ- R2- RIG RNS RPZ SEW SOHCF SSZ SV3 TBHMF TDRGL ZKB 3V. 7TK 7XB 8FE 8FH 8FK ABRTQ K9. LK8 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c431t-d812931d7c4079c362972562b52f7fcc2aad24619075022b2c3086a34eb6c8693 |
IEDL.DBID | 7X7 |
ISSN | 0893-133X 1740-634X |
IngestDate | Thu Aug 21 18:33:03 EDT 2025 Fri Jul 11 16:03:48 EDT 2025 Sat Aug 23 12:44:04 EDT 2025 Thu Apr 03 07:09:13 EDT 2025 Tue Jul 01 01:05:47 EDT 2025 Thu Apr 24 23:07:30 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c431t-d812931d7c4079c362972562b52f7fcc2aad24619075022b2c3086a34eb6c8693 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0001-5180-6694 0000-0002-4381-224X |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC11251178 |
PMID | 38714786 |
PQID | 3080876760 |
PQPubID | 33935 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11251178 proquest_miscellaneous_3052595689 proquest_journals_3080876760 pubmed_primary_38714786 crossref_citationtrail_10_1038_s41386_024_01876_5 crossref_primary_10_1038_s41386_024_01876_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-08-01 |
PublicationDateYYYYMMDD | 2024-08-01 |
PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York – name: Cham |
PublicationTitle | Neuropsychopharmacology (New York, N.Y.) |
PublicationTitleAlternate | Neuropsychopharmacology |
PublicationYear | 2024 |
Publisher | Nature Publishing Group Springer International Publishing |
Publisher_xml | – name: Nature Publishing Group – name: Springer International Publishing |
References | Y Benjamini (1876_CR47) 1995; 57 JG Ramaekers (1876_CR6) 2021; 22 JM Gilman (1876_CR21) 2019; 197 NL Mason (1876_CR50) 2021; 26 GD Pearlson (1876_CR10) 2021; 12 TR Arkell (1876_CR12) 2021; 22 U Braun (1876_CR56) 2015; 112 D McCartney (1876_CR61) 2022; 134 RW Homan (1876_CR36) 1987; 66 F Scholkmann (1876_CR40) 2010; 31 M van Schouwenburg (1876_CR8) 2010; 16 1876_CR63 1876_CR20 E Pabon (1876_CR58) 2022; 59 SM Eggan (1876_CR1) 2006; 17 R Vandrey (1876_CR64) 2017; 41 R Levy (1876_CR7) 2023; 147 JG Ramaekers (1876_CR4) 2016; 10 MAP Bloomfield (1876_CR27) 2016; 539 NL Mason (1876_CR28) 2019; 29 T Mei (1876_CR46) 2022; 11 XN Zuo (1876_CR44) 2010; 49 JG Ramaekers (1876_CR62) 2023; 80 JM Gilman (1876_CR13) 2022; 47 P Pinti (1876_CR17) 2015; 5 S Sidney (1876_CR59) 2002; 42 JG Ramaekers (1876_CR26) 2022; 12 A Weinstein (1876_CR2) 2008; 196 L Douw (1876_CR55) 2016; 339 D McCartney (1876_CR11) 2021; 126 SA Meda (1876_CR45) 2015; 41 MB Wall (1876_CR25) 2019; 33 1876_CR33 ZQ Gong (1876_CR57) 2021; 19 M Ranganathan (1876_CR5) 2006; 188 GJ Thompson (1876_CR53) 2013; 34 1876_CR9 M Cope (1876_CR39) 1988; 26 CW Myers (1876_CR60) 2001; 91 L Hocke (1876_CR38) 2018; 11 AZ Snyder (1876_CR41) 2012; 62 MA Huestis (1876_CR34) 1998; 20 JB Balardin (1876_CR15) 2017; 11 JM Gilman (1876_CR23) 2022; 47 ME Raichle (1876_CR24) 2007; 37 S Bhattacharyya (1876_CR49) 2012; 69 P Pinti (1876_CR18) 2020; 1464 R McKendrick (1876_CR16) 2016; 10 F Zhou (1876_CR43) 2017; 15 HH van Hell (1876_CR51) 2011; 14 ME Morean (1876_CR35) 2013; 227 I Cribben (1876_CR32) 2012; 61 MG Bossong (1876_CR31) 2013; 8 Y Zhang (1876_CR42) 2020; 13 WM Bosker (1876_CR3) 2013; 8 S Bhattacharyya (1876_CR30) 2015; 25 C Chang (1876_CR54) 2013; 68 HO Keles (1876_CR22) 2017; 11 S Bhattacharyya (1876_CR29) 2015; 40 JG Ramaekers (1876_CR14) 2020; 36 1876_CR52 G Battistella (1876_CR48) 2013; 8 S Lloyd-Fox (1876_CR19) 2010; 34 TJ Huppert (1876_CR37) 2009; 48 |
References_xml | – volume: 49 start-page: 1432 year: 2010 ident: 1876_CR44 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2009.09.037 – volume: 66 start-page: 376 year: 1987 ident: 1876_CR36 publication-title: Electroencephalogr Clin Neurophysiol doi: 10.1016/0013-4694(87)90206-9 – volume: 539 start-page: 369 year: 2016 ident: 1876_CR27 publication-title: Nature doi: 10.1038/nature20153 – volume: 11 start-page: 349 year: 2022 ident: 1876_CR46 publication-title: Transl Pediatr doi: 10.21037/tp-21-412 – volume: 34 start-page: 269 year: 2010 ident: 1876_CR19 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2009.07.008 – volume: 147 start-page: 794 year: 2023 ident: 1876_CR7 publication-title: Brain doi: 10.1093/brain/awad389 – volume: 1464 start-page: 5 year: 2020 ident: 1876_CR18 publication-title: Ann NY Acad Sci doi: 10.1111/nyas.13948 – volume: 10 start-page: 216 year: 2016 ident: 1876_CR16 publication-title: Front Hum Neurosci doi: 10.3389/fnhum.2016.00216 – volume: 26 start-page: e12870 year: 2021 ident: 1876_CR50 publication-title: Addiction Biol doi: 10.1111/adb.12870 – ident: 1876_CR63 doi: 10.31707/VDR2019.5.1.p31 – volume: 14 start-page: 1377 year: 2011 ident: 1876_CR51 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145711000526 – volume: 48 start-page: D280 year: 2009 ident: 1876_CR37 publication-title: Appl Opt doi: 10.1364/AO.48.00D280 – volume: 69 start-page: 27 year: 2012 ident: 1876_CR49 publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2011.161 – volume: 91 start-page: 62 year: 2001 ident: 1876_CR60 publication-title: Auton Neurosci doi: 10.1016/S1566-0702(01)00289-2 – volume: 26 start-page: 289 year: 1988 ident: 1876_CR39 publication-title: Med Biol Eng Comput doi: 10.1007/BF02447083 – volume: 8 start-page: e53127 year: 2013 ident: 1876_CR3 publication-title: Plos One doi: 10.1371/journal.pone.0053127 – volume: 11 start-page: 258 year: 2017 ident: 1876_CR15 publication-title: Front Hum Neurosci doi: 10.3389/fnhum.2017.00258 – volume: 31 start-page: 649 year: 2010 ident: 1876_CR40 publication-title: Physiol Meas doi: 10.1088/0967-3334/31/5/004 – volume: 16 start-page: 2026 year: 2010 ident: 1876_CR8 publication-title: Curr Pharm Des doi: 10.2174/138161210791293097 – volume: 8 start-page: e70074 year: 2013 ident: 1876_CR31 publication-title: PLoS One doi: 10.1371/journal.pone.0070074 – volume: 47 start-page: 944 year: 2022 ident: 1876_CR23 publication-title: Neuropsychopharmacology doi: 10.1038/s41386-021-01259-0 – volume: 33 start-page: 822 year: 2019 ident: 1876_CR25 publication-title: J Psychopharmacol doi: 10.1177/0269881119841568 – ident: 1876_CR33 doi: 10.1007/978-3-030-32254-0_17 – volume: 57 start-page: 289 year: 1995 ident: 1876_CR47 publication-title: J R Stat Soc, Ser B doi: 10.1111/j.2517-6161.1995.tb02031.x – volume: 197 start-page: 575 year: 2019 ident: 1876_CR21 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2019.05.012 – ident: 1876_CR52 doi: 10.1038/s41386-024-01809-2 – volume: 42 start-page: 64S year: 2002 ident: 1876_CR59 publication-title: J Clin Pharm doi: 10.1002/j.1552-4604.2002.tb06005.x – volume: 20 start-page: 570 year: 1998 ident: 1876_CR34 publication-title: Ther Drug Monit doi: 10.1097/00007691-199810000-00021 – volume: 11 start-page: 67 year: 2018 ident: 1876_CR38 publication-title: Algorithms doi: 10.3390/a11050067 – volume: 227 start-page: 177 year: 2013 ident: 1876_CR35 publication-title: Psychopharmacol (Berl) doi: 10.1007/s00213-012-2954-z – volume: 47 start-page: 944 year: 2022 ident: 1876_CR13 publication-title: Neuropsychopharmacology doi: 10.1038/s41386-021-01259-0 – volume: 19 start-page: 529 year: 2021 ident: 1876_CR57 publication-title: Neuroinformatics doi: 10.1007/s12021-020-09500-9 – volume: 12 year: 2022 ident: 1876_CR26 publication-title: Sci Rep. doi: 10.1038/s41598-022-06509-9 – ident: 1876_CR20 doi: 10.3791/53336 – volume: 41 start-page: 83 year: 2017 ident: 1876_CR64 publication-title: J Anal Toxicol doi: 10.1093/jat/bkx012 – volume: 188 start-page: 425 year: 2006 ident: 1876_CR5 publication-title: Psychopharmacology doi: 10.1007/s00213-006-0508-y – volume: 5 year: 2015 ident: 1876_CR17 publication-title: Sci Rep. doi: 10.1038/srep17471 – volume: 134 start-page: 104433 year: 2022 ident: 1876_CR61 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2021.11.004 – volume: 40 start-page: 1343 year: 2015 ident: 1876_CR29 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2014.258 – volume: 34 start-page: 3280 year: 2013 ident: 1876_CR53 publication-title: Hum Brain Mapp doi: 10.1002/hbm.22140 – volume: 29 start-page: 247 year: 2019 ident: 1876_CR28 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2018.12.003 – volume: 80 start-page: 871 year: 2023 ident: 1876_CR62 publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2023.2309 – volume: 126 start-page: 175 year: 2021 ident: 1876_CR11 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2021.01.003 – volume: 11 start-page: 488 year: 2017 ident: 1876_CR22 publication-title: Front Hum Neurosci doi: 10.3389/fnhum.2017.00488 – volume: 59 start-page: e13955 year: 2022 ident: 1876_CR58 publication-title: Psychophysiology doi: 10.1111/psyp.13955 – volume: 22 start-page: 102 year: 2021 ident: 1876_CR12 publication-title: Traffic Inj Prev doi: 10.1080/15389588.2020.1851685 – volume: 15 start-page: 458 year: 2017 ident: 1876_CR43 publication-title: Neuroimage Clin doi: 10.1016/j.nicl.2016.05.011 – volume: 10 start-page: 1254 year: 2016 ident: 1876_CR4 publication-title: Brain Imaging Behav doi: 10.1007/s11682-015-9488-z – volume: 8 start-page: e52545 year: 2013 ident: 1876_CR48 publication-title: Plos One doi: 10.1371/journal.pone.0052545 – volume: 25 start-page: 26 year: 2015 ident: 1876_CR30 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2014.11.018 – volume: 196 start-page: 119 year: 2008 ident: 1876_CR2 publication-title: Psychopharmacology doi: 10.1007/s00213-007-0940-7 – volume: 37 start-page: 1083 year: 2007 ident: 1876_CR24 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2007.02.041 – ident: 1876_CR9 – volume: 22 start-page: 439 year: 2021 ident: 1876_CR6 publication-title: Nat Rev Neurosci doi: 10.1038/s41583-021-00466-4 – volume: 12 start-page: 689444 year: 2021 ident: 1876_CR10 publication-title: Front Psychiatry doi: 10.3389/fpsyt.2021.689444 – volume: 36 start-page: 191 year: 2020 ident: 1876_CR14 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2020.01.006 – volume: 41 start-page: 1336 year: 2015 ident: 1876_CR45 publication-title: Schizophr Bull doi: 10.1093/schbul/sbv064 – volume: 17 start-page: 175 year: 2006 ident: 1876_CR1 publication-title: Cereb Cortex doi: 10.1093/cercor/bhj136 – volume: 339 start-page: 12 year: 2016 ident: 1876_CR55 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2016.09.034 – volume: 61 start-page: 907 year: 2012 ident: 1876_CR32 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.03.070 – volume: 62 start-page: 902 year: 2012 ident: 1876_CR41 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.01.044 – volume: 13 start-page: 1430 year: 2020 ident: 1876_CR42 publication-title: Front Neurosci doi: 10.3389/fnins.2019.01430 – volume: 68 start-page: 93 year: 2013 ident: 1876_CR54 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.11.038 – volume: 112 start-page: 11678 year: 2015 ident: 1876_CR56 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1422487112 |
SSID | ssj0015768 |
Score | 2.4675992 |
Snippet | Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1481 |
SubjectTerms | Acute intoxication Adolescent Adult Cannabinoid Receptor Agonists - administration & dosage Cannabinoid Receptor Agonists - pharmacology Cannabinoid receptors Cannabinoids Cannabis Cross-Over Studies Double-Blind Method Dronabinol - administration & dosage Dronabinol - pharmacology Female Heart rate Heart Rate - drug effects Humans Infrared spectroscopy Intoxication Male Marijuana Middle Aged Neural networks Neuroimaging Placebos Prefrontal cortex Prefrontal Cortex - drug effects Spectroscopy, Near-Infrared Tetrahydrocannabinol THC Young Adult |
Title | Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38714786 https://www.proquest.com/docview/3080876760 https://www.proquest.com/docview/3052595689 https://pubmed.ncbi.nlm.nih.gov/PMC11251178 |
Volume | 49 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwEB5BKyEuCLb8BEplJNQLtbpJHMc5oQKtWhBVhVppb5Fje9WVSrI0WanLc_BcPBMzjjdlQeoxsp04mvHMN_b4G4C3LlNT4aTieSYtF5UQvNBWcSeTyuhCj6X22Ran8vhCfJ5kk7Dh1oa0ypVN9IbaNob2yPdThDa4cnM5fj__walqFJ2uhhIa92GTqMtIq_PJEHDFhKU9iixSjrHYJFyaGadqv0XjrSj9lnIw8L08W3dM_6HNf5Mm__JCR4_hUYCP7KCX9xO45-oRbB3UGDp_X7Jd5hM6_U75CB58DefmI9g96xmql3vs_PbCVbvnRwzc1cstcCd119yEfTxmF451Dfv9q-Cdw-lcLi36O13XGuPp5orNWmYGwuefzrJqyeysvV7MEceyOf4j0SPgfA2l9N4wukRBtSqewsXR4fnHYx4qMXCDAKPjVhEsiG1uMP4rDDq9IkeslFRZMs2nxiRaWyKmKwiAJEmVGBSX1KlwlTRKFukz2Kib2r0AZlKX4EAnppUUyhrt0MKNhXAIfLCrjSBeiaE0gaacqmVclf64PFVlL7oSRVd60ZVZBO-GMfOepOPO3tsr6ZZhwbblrXpF8GZoxqVG5ye6ds2C-mQYLGZSFRE875Vh-FyKgafIlYxAranJ0IFovNdb6tmlp_OOCWPGuXp597xewcPEqyslH27DRne9cK8REHXVjtf6Hdj8cHh69g2fPp18-QPg5Qz9 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELaqIgEXBFugWwoYCXqhVrOO4zgHhCqg2qU_4rCV9hYc26uuVJJtkxUNz8Fz8Cg8EzNONmVB6q1n27GjGc_MZ4-_IeS1i9RUOKlYHEnLRCYES7RVzEmeGZ3oQGqfbXEih6fi8ySarJFfy7cwmFa5tIneUNvC4Bn5XgihDezcWAbv5xcMq0bh7eqyhEajFoeu_g6QrXw3-gjyfcP5wafxhyFrqwowA86yYlahixvY2ACWSQwY8CQGv8-ziE_jqTFca4skawk6U84zbmBqqUPhMmmURPIlMPl34FsBgr140gG8AcbuPmpNQgbYb9I-0glCtVeCs1CY7os5H_AfLFp1hP9Ft_8maf7l9Q4ekgdtuEr3G_16RNZc3iMb-zlA9W813aE-gdSfzPfI3eP2nr5Hdr40jNj1Lh1fP_Aqd_2Ijiu73iBulFfFVXtuSO3C0aqgv38mrHKwnLPagn_Vea4BvxfndFZS0xFM_3CWZjW1s_JyMYe4mc7hH5GOAdZrMIX4iuKjDayN8Zic3oqMnpD1vMjdJqEmdBwGOjHNpFDWaAcWNRDCQaAFXW2fDJZiSE1Li47VOc5Tfz0fqrQRXQqiS73o0qhP3nZj5g0pyI29t5fSTVsDUabX6twnr7pm2Np4X6NzVyywTwTgNJIq6ZOnjTJ004UAdEWsZJ-oFTXpOiBt-GpLPjvz9OEDjGkHsdq6eV0vyb3h-PgoPRqdHD4j97lXXUx83Cbr1eXCPYdgrMpe-B1Aydfb3nJ_AKaQRLs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbtMwFLamTpq4QdDxkzHASLAbZrV1HMe5QGiwVSuDqkKb1Lvg2K5WaSRlScXCc_A0PATPxDlJmlGQdrdr24qj8_cdn-PPhLx0gZoJJxULA2mZSIRgkbaKOckToyPdl7rqthjL4zPxYRpMN8iv1V0YbKtc-cTKUdvM4Bl5zwdoA5Ybyn5v1rRFTA6HbxffGL4ghZXW1XMatYqcuPI7pG_5m9EhyPoV58Oj0_fHrHlhgBkInAWzCsPdwIYG8prIgDOPQsAAPAn4LJwZw7W2SLgWYWDlPOEGtiG1L1wijZJIxATufzPErKhDNt8djSef2xoGIvkKw0Y-g0xw2lzZ6fuql0PoUNj8ix0g8FcsWA-L_2Hdf1s2_4qBw3vkbgNe6UGtbffJhku7ZPsghcT9a0n3aNVOWp3Td8nWp6Zq3yV7k5ofu9ynp9fXvfL9akXLnF1uEzdKi-yqOUWkdulokdHfPyNWONjOeWkh2uo01ZDNZxd0nlPT0k3_cJYmJbXz_HK5ABRNF_CPSM4A-zXYUHxF8QoHvpTxgJzdipQekk6ape4xocZ3HBY6MUukUNZoB_61L4QD2AVTrUcGKzHEpiFJx7c6LuKqWO-ruBZdDKKLK9HFgUdet2sWNUXIjbN3V9KNG3eRx9fK7ZEX7TAYOlZvdOqyJc4JIFUNpIo88qhWhvZzPqS9IlTSI2pNTdoJSCK-PpLOzysy8QEi3EGodm7e13OyBeYWfxyNT56QO7zSXOyC3CWd4nLpngIyK5JnjQlQ8uW2re4PbIBKVg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intoxication+due+to+%CE%949-tetrahydrocannabinol+is+characterized+by+disrupted+prefrontal+cortex+activity&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Karunakaran%2C+Keerthana+Deepti&rft.au=Pascale%2C+Michael&rft.au=Ozana%2C+Nisan&rft.au=Potter%2C+Kevin&rft.date=2024-08-01&rft.issn=1740-634X&rft.eissn=1740-634X&rft.volume=49&rft.issue=9&rft.spage=1481&rft_id=info:doi/10.1038%2Fs41386-024-01876-5&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon |